Haemonetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. 

CEO
Christopher A. Simon
CEOChristopher A. Simon
Employees
3,023
Employees3,023
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1971
Founded1971
Employees
3,023
Employees3,023

HAE Key Statistics

Market cap
3.36B
Market cap3.36B
Price-Earnings ratio
21.17
Price-Earnings ratio21.17
Dividend yield
Dividend yield
Average volume
493.44K
Average volume493.44K
High today
$70.80
High today$70.80
Low today
$69.74
Low today$69.74
Open price
$69.84
Open price$69.84
Volume
467.32K
Volume467.32K
52 Week high
$94.99
52 Week high$94.99
52 Week low
$55.30
52 Week low$55.30

HAE News

Simply Wall St 7d
Market Participants Recognise Haemonetics Corporation's Earnings

Haemonetics Corporation's ( ) price-to-earnings (or "P/E") ratio of 20.5x might make it look like a sell right now compared to the market in the United States,...

Market Participants Recognise Haemonetics Corporation's Earnings

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.